Alembic Pharmaceuticals Limited Financial Overview
Alembic Pharmaceuticals Limited's market cap is currently ₹166.32B. The company's EPS TTM is ₹9.4; its P/E ratio is 26.22; and it has a dividend yield of 1.30%. Alembic Pharmaceuticals Limited is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is ₹8.30. See an overview of income statement, balance sheet, and cash flow financials.
